4-Thiazoleacetic acid, 2-amino-, ethyl ester → HCID 10135762, compound
Reaction equation
[NH2:1][C:2]1[S:3][CH:4]=[C:5]([CH2:7][C:8]([O:10][CH2:11][CH3:12])=[O:9])[N:6]=1.[Cl:13][C:14]1[C:22]2[C:18](=[N:19][O:20][N:21]=2)[C:17]([S:23](Cl)(=[O:25])=[O:24])=[CH:16][CH:15]=1>>[Cl:13][C:14]1[C:22]2=[N:21][O:20][N:19]=[C:18]2[C:17]([S:23]([NH:1][C:2]2[S:3][CH:4]=[C:5]([CH2:7][C:8]([O:10][CH2:11][CH3:12])=[O:9])[N:6]=2)(=[O:24])=[O:25])=[CH:16][CH:15]=1Participants
3
Procedure
The title compound was prepared from ethyl 2-amino-4-thiazolylacetate and 4-chloro-7-chlorosulfonyl-2,1,3-benzoxadiazole as described in the synthetic METHOD B to give a yellow solid (2.5 mg) with purity >90%. MS (pos) m/z 403.4.
Sources & evidence
- ORD record
- ord-85629e6987474b1ba931467f3cfdd1eb
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07618961B2
Reaction notes
Loading…